Granulomatous anterior uveitis associated with 0.2% topical brimonidine [15]

Eye

Volumn 17, Issue 5, 2003, Pages 670-671

  Cates, Carolyn A ^a   Jeffrey, M N ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CYCLOPENTOLATE; DEXAMETHASONE; LATANOPROST; STEROID; TIMOLOL;

AGED; ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; CASE REPORT; CONJUNCTIVA DISEASE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EYE DISEASE; EYE INFLAMMATION; FEMALE; GRANULOMATOSIS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; LABORATORY TEST; LETTER; OPEN ANGLE GLAUCOMA; PROVOCATION TEST; RETINA MACULA AGE RELATED DEGENERATION; VISUAL DISORDER;

EID: 0042669881     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700392     Document Type: Letter

References (5)

1. Byles DB, Frith P, Salmon JF. Anterior uveitis, as a side effect of topical brimonidine. Am J Ophthalmol 2000; 130: 287-291.
2. Goyal R, Ram AR. Brimonidine tartrate 0.2% (Alphagan) associated granulomatous anterior uveitis. Eye 2000; 14: 908-910.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al. A method for establishing the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
4. Blondeau P, Rousseau JA. Allergic reactions to brimonidine in patients treated for glaucoma. Can J Ophthalmol 2002; 37: 21-26.
5. Katz LJ. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% given twice daily: 1-year results in glaucoma patients. Brimonidine Study Group. Am J Ophthalmol 1999; 127: 20-26.